Viewing Study NCT00686166


Ignite Creation Date: 2025-12-24 @ 4:43 PM
Ignite Modification Date: 2026-03-11 @ 11:44 PM
Study NCT ID: NCT00686166
Status: COMPLETED
Last Update Posted: 2018-05-18
First Post: 2008-05-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
Sponsor: SWOG Cancer Research Network
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: S0713
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View